Ticagrelor Ticagrelor Ticagrelor (trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor produced by AstraZeneca. Ticagrelor is an antagonist of the P2Y receptor. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011. Ticagrelor is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation. The drug is combined with acetylsalicylic acid unless the latter is contraindicated. There is no high
Acid test (gold) to assess the liquidity of a business. The use of the term "acid test" for experiences with the psychedelic drug LSD was popularised by the Merry Pranksters, and derives from the drug's common name, "acid". Acid test (gold) An acid test is any qualitative chemical or metallurgical assay which uses acid; most commonly, and historically, the use of a strong acid to distinguish gold from base metals. Figuratively, acid test is any definitive test for some attribute, e.g. of a person's character, or of the performance of product. Testing for gold with acid focuses on the fact that gold is